11-Oxomogroside IIa

11-Oxomogroside IIa (11-oxomogroside II A1) is a cucurbitane glycoside extracted from the fruits of Siraitia grosVenorii. 11-Oxomogroside IIa has inhibitory effects against the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), shows weak inhibitory effects on activation of (+/-) - (E) -methyl-2-[ (E) -hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor[1].

Product Specifications

UNSPSC

12352005

Target

EBV; HSV

Type

Natural Products

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/11-oxomogroside-iia.html

Purity

99.9

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

C[C@H](CC[C@@H](O[C@H]1[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)C(C)(O)C)C3CC[C@@]([C@]3(C)C4)(C)C5CC=C6C(C)(C)[C@@H](O)CCC6[C@]5(C)C4=O

Molecular Formula

C42H70O14

Molecular Weight

799.00

References & Citations

[1]Akihisa T, et al. Cucurbitane glycosides from the fruits of Siraitia gros venorii and their inhibitory effects on Epstein-Barr virus activation. J Nat Prod. 2007 May;70 (5) :783-8. Epub 2007 May 4.